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Abstract. Myofibromatosis is an uncommon disorder of 
infancy, characterized by proliferation of myofibroblasts 
in solitary or multiple nodules. The clinical characteristics 
depend on the involved sites: Myofibromatosis may develop 
as a musculoskeletal form, with non-painful swellings and 
eventual mass effect symptoms, or as a generalized form with 
visceral involvement and organ failure. Prognosis and therapy 
vary between the abovementioned patterns. When there is no 
visceral involvement, the tumors may regress spontaneously; 
however, the visceral form may represent a lifethreatening 
condition with poor outcome and it requires aggressive manage-
ment. Imaging assessment of disease spread is mandatory to 
determine diagnosis, prognosis and therapy. Due to the young 
age of the patients, a radiation-free evaluation is recommended. 
We herein describe a case of musculoskeletal myofibromatosis 
diagnosed in a 3-month-old male infant, investigated by serial 
wholebody magnetic resonance imaging (MRI) examination. 
The histological analysis and MRI characteristics enabled a 
correct diagnosis and organ involvement assessment with no 
radiation exposure. Moreover, whole-body MRI sequences 
provided a detailed evaluation of the disease within a short 
time frame, reducing the time of sedation, which is required to 
perform MRI in very young patients. Therefore, whole-body 
MRI was found to be accurate and safe in the diagnosis and 
follow-up of multicentric infantile myofibromatosis.
Introduction
Myofibromatosis is the most common fibrous tumor of infancy 
or childhood, often misdiagnosed due to its variable clinical 
and imaging characteristics; the differential diagnosis includes 
metastatic neuroblastoma, rhabdomyosarcoma, histiocytosis X 
or hemangiopericytoma (1-3). Examination of a pathological 
specimen is mandatory for ruling out malignancies that may 
require different management (4).
The clinical behavior of myofibromatosis may vary 
between a benign solitary or multicentric form, with involve-
ment of muscles, bones and subcutaneous tissues, and a diffuse 
multicentric form with visceral involvement and a worse 
prognosis (1,4). Conservative management and observation are 
preferred for the solitary or multicentric forms without visceral 
involvement, as they usually undergo spontaneous regression; 
occasionally, surgery is suggested to reduce eventual mass 
effect symptoms. Aggressive treatment with radiotherapy, 
chemotherapy and radical surgery is used for disseminated 
forms with visceral involvement (1,4,5).
Clinical/radiological diagnosis and follow-up are crucial 
for determining disease localization and prognosis (6).
We herein describe a case of multicentric musculoskeletal 
myofibromatosis, investigated with whole-body magnetic 
resonance imaging (MRI) to assess different lesions without 
X-ray exposure, in order to follow disease evolution and/or 
regression, including early exclusion of visceral involvement, 
which is mandatory for prognosis and treatment.
Case report
A 3-month-old male infant, asymptomatic, born to term after 
an uneventful pregnancy, without a noteworthy family history, 
was referred to the University Hospital Paolo Giaccone in 
April, 2014, due to multiple, firm, painless swellings on the 
trunk and abdomen, covered by flesh-coloured skin.
The laboratory tests were inconclusive and misleading, 
including a mild increase in neuronspecific enolase to 27 ng/ml 
(normal, <15 ng/ml).
An ultrasound (US) examination revealed multiple 
heterogeneously hypoechogenic lesions, with scarce inner and 
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peripheral vascularization, located in the left breastplate, right 
deep intercostal muscles and the rectus abdominis muscles 
bilaterally. Grade 2 left pyelectasis was also detected on 
abdominal US (image not shown).
Due to the suspicion of neuroblastoma based on US exami-
nation and laboratory tests, a nodule located in the right rectus 
muscle was selected for removal, due to its easy accessibility 
and low deep subcutaneous invasion, and was subsequently 
analyzed by histology. The tumor was characterized by tangles 
of spindleshaped elements, it was smooth muscle actin (SMA)+, 
desmin- and S100-, rich in cellular components in the periphery 
and exhibiting central hyalinization. No mitotic activity or cell 
atypia were identified, and the diagnosis of infantile myofibro-
matosis was established.
Whole-body MRI was performed for panoramic localiza-
tion of the nodules using short TI inversion recovery (STIR) 
and diffusion-weighted whole-body imaging with background 
body signal suppression (DWIBS) sequences in the coronal 
or axial planes and volumetric 3D reformatting, to provide a 
detailed assessment of the lesions and an accurate estimation 
of the disease status.
The MRI revealed a significant number of nodules (~70 
lesions), with almost exclusive muscle localization, in the head, 
trunk, abdomen, and upper and lower limbs.
STIR revealed multiple widespread lesions, character-
ized by a hyperintense core, surrounded by a rim of low 
signal (Fig. 1). The largest lesion was detected in the left 
iliopsoas muscle (34x26x20 mm), whereas no compression or 
infiltration of adjacent tissues was observed, other than mild 
ureteral compression.
DWIBS displayed multiple widespread loci of high inten-
sity (Fig. 2), which on the apparent diffusion coefficient map 
exhibited an intermediate inner signal and a lower signal on 
their rim.
A blurred mass in the IX right rib was also identified; thus, 
to assess bone invasion and lung involvement, an unenhanced 
lowdose computed tomography (CT) scan was performed, 
which revealed a round cortical enlargement, but without a 
sclerotic rim, in the IX rib; the lungs were of otherwise normal 
appearance.
On the basis of the histological and radiological char-
acteristics, the diagnosis of multicentric musculoskeletal 
myofibromatosis without visceral involvement was confirmed. 
Clinical observation was considered the best approach in this 
case. The patient was discharged after 1 week and follow-up 
with clinical examination and whole-body MRI re-evaluation 
was performed at 1 year, demonstrating a reduction in the 
size and number of the lesions (Fig. 3). A noticeable regres-
sion of disease was achieved and further clinical follow-up 
was scheduled. The last physical examination was performed 
2 years after the first referral, reporting no palpable nodules 
or other symptoms. Therefore, no further hospital follow-up 
was planned. The patient’s parents gave their consent to the 
publication of the case details and associated images.
Discussion
Myofibromatosis is the most common fibrous tumor of child-
hood, with 88% of the cases occurring prior to the age of 
2 years. The lesions may be present at birth, or may develop 
during early infancy; solitary tumors mainly affect males, 
whilst the multicentric form is more common in females (1,7). 
The precise etiology remains unknown, but genetic factors, 
autosomal dominant as well as recessive, appear to be impli-
cated (5).
Myofibromatosis clinically presents as single mass or 
diffuse multiple nodules that may develop anywhere, from 
the skin to subcutaneous tissues or viscera, characterized by 
spindle-shaped cells, SMA and vimentin positivity, related to 
myofibroblast proliferation; the lesions are often associated 
with richly vascular central areas, hemangiopericytomalike, 
frequently displaced by sheets of hyalinization or necrosis and 
calcification due to extensive apoptosis (3-5). According to 
several authors, hemangiopericytoma and infantile myofibro-
matosis are a continuous spectrum of a single myofibroblast 
disease (8). Therefore, the appearance on radiological investi-
gation may vary on the basis of the abovementioned criteria (6).
Prognosis and treatment depend on the disease type, 
namely the solitary or multicentric form with subcutaneous, 
muscular and osseous involvement, or the multicentric form 
with visceral spread. Solitary or multicentric disease without 
visceral involvement is usually associated with a very good 
prognosis with spontaneous regression, whereas the multi-
Figure 1. Short T1 inversion recovery sequence, coronal plane. The largest 
lesion was located in the left iliopsoas muscle, with multiple smaller masses 
in the lower limbs. The lesions display a hyperintense core with a lower/
intermediate peripheral intensity.
MOLECULAR AND CLINICAL ONCOLOGY  6:  579-582,  2017 581
centric form with visceral spread requires aggressive surgery 
and/or radiotherapy and chemotherapy; however, the prognosis 
is often poor, particularly when the lungs are involved (1,4,5). 
A solitary visceral form has rarely been reported, and its 
prognosis and treatment depend on the involved organ and 
associated symptoms (7).
For the abovementioned reasons, the determination of 
disease extent and progression with imaging are mandatory (6). 
US is the firststep examination, due to its availability, lack of 
ionizing radiation, and no need for sedation; however, the 
findings are often nonspecific, and US cannot fully investigate 
deep lesions, bone spread, visceral and lung involvement (3).
The lesions of myofibromatosis appear on CT scan as 
masses that exhibit soft tissue attenuation, or mildly higher, 
although lower attenuation is also possible due to necrosis, 
and sparse hyperdense loci of calcification may be present as 
well (3,5).
However, CT scan should be avoided when possible, due 
to ionizing radiation exposure and its relatively low contrast 
resolution for soft tissues. CT should be limited to determining 
eventual lung or bone involvement; the latter is usually seen as 
lytic lesions, with or without cortical sclerosis, which is more 
commonly observed when the lesions start to heal. Pulmonary 
involvement is usually correlated with a worse prognosis (3-5).
MRI is considered a gold standard imaging technique for 
soft tissue evaluation, due to its ability to provide a radiation-
free detailed assessment of the disease, even without contrast 
media administration; it also enables early detection of 
visceral involvement in myofibromatosis (6). MRI may also 
provide high-accuracy musculoskeletal images and distinguish 
between various tissues, such as muscle, fibrous tissue and fat.
In radiological literature, myofibromatosis nodules 
usually display different MRI signals, depending on the main 
pattern of the lesions, or on their ‘age’, according to several 
authors (5,8): Younger nodules, characterized by an immature, 
highly vascular central component (hemangiopericytoma like) 
surrounded by bundles of myofibroblasts, are iso/hypointense 
on T1W images before and after contrast compound administra-
tion, and exhibit heterogeneous gadolinium (Gd) enhancement 
and high signal on T2W sequences (5,6). In older lesions, the 
immature core is replaced by mature myofibroblasts, or more 
often involutes in sheets of hyalinization or necrosis and calci-
fication. T1W sequences usually reveal intermediate or lower 
intensity compared with the surrounding muscle, and noticeable 
peripheral heterogeneous Gd enhancement (target appearance), 
whereas in T2W images they display a hyperintense core due 
to central necrosis. Inner low signal foci in all sequences are 
detected in case of inner lesion calcifications (3,5,6).
MRI plays a pivotal role in cases of widespread soft tissue 
nodules characterized by myofibroblast proliferation in pedi-
atric patients, particularly when performed as whole-body 
MRI, in order to evaluate multiple diffuse lesions (9).
Until recently, whole-body evaluation of multicentric 
disease was only performed by nuclear medicine, involving 
exposure to high doses of radiation. MRI, due to the new dedi-
cated coils, self-sliding table, new reconstruction software and 
use of fast sequences, may substitute PET in certain cases of 
cancer staging and in other systemic diseases (9).
Whole-body MRI enables a complete imaging survey 
within a short time and allows panoramic detailed imaging 
Figure 3. Short T1 inversion recovery sequence, coronal plane. At the 1-year 
follow-up, the size of the iliopsoas lesion was found to be reduced, appearing 
heterogeneously hyperintense. Lower limb masses were no longer detectable.
Figure 2. Diffusion-weighted whole-body imaging with background body 
signal suppression 3D volumetric reformatting. Multiple lesions exhibited a 
water restriction signal in the abdomen and lower limbs. The largest lesion 
was identified in the left iliopsoas muscle.
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of all lesions sized >6 mm, it is able to investigate spread to 
contiguous organs and may also be used in the follow-up to 
determine lesion reduction and shrinkage, as in the present 
case. Fast image acquisition is also useful in pediatric patients 
to reduce sedation time during MRI acquisition (9,10).
Although there is no standardized technique for performing 
whole-body MRI, the main sequences are STIR and DWIBS. 
T1W, with or without contrast administration, increases speci-
ficity, but it is not routinely performed as it prolongs scanning 
time (10).
The application of STIR sequences in pediatric MRI is 
well accepted, since the signal may aid in differentiating tissue 
characteristics; in fact, the majority of the pathological lesions 
are proton-rich and have extended T1 and T2 relaxation times, 
exhibiting high signal on STIR, along with its ability to provide 
images within a short time frame and to better suppress fat 
signal compared with other T2 fat-saturated sequences (9,10).
DWIBS sequences provide information on lesion architec-
ture and enable functional 3D imaging of systemic disease in 
freebreathing acquisition, depicting highly cellular tumors and 
necrosis as high-signal lesions (9,10).
Moreover, DWIBS acquisitions can be postprocessed, 
obtaining whole-body images in coronal planes and, inverting 
the grey scale, it is possible to create PET-like images (9).
Whole-body MRI is a well-accepted imaging modality for 
staging lymphoma; this modality has been extended to the safe 
evaluation of other systemic diseases, found to be useful when 
a whole-body panoramic assessment of a disease is required, 
not only to establish its true extent, but also during follow-up 
to determine its evolution (6,9). It must be mentioned that the 
sensitivity of whole-body MRI with T1 and STIR sequences 
is comparable to that of PET/CT in the detection of metastatic 
diseases. DWIBS sequences increase sensitivity by demon-
strating tissue cellular architecture (9).
Whole-body MRI has shown to be able to provide a 
detailed panoramic view of systemic disease along with func-
tional information within a reasonable time frame, without 
breath holding and without radiation exposure, in a single 
short sedation session. In the present case, whole-body MRI 
easily assessed all the sites of myofibromatosis lesions, and 
provided detailed information regarding the extent of the 
disease, spread in contiguous organs and its evolution during 
follow-up.
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